Column

Worried About Your Stomach and Kidneys From Long-Term NSAIDs? Joint Treatment Options Explained by Dr. Moriwaki2026.09.11

Many people take painkillers (NSAIDs) almost daily for chronic knee or back pain. But when the routine dependence on stomach medication or a checkup flagging worsening kidney function makes them ask, “Is it really safe to keep taking these?”, more and more patients want a way out of painkillers. Long-term NSAID use raises the risk of gastrointestinal bleeding and chronic kidney injury in a stepwise manner, and even from a purely medical standpoint, it is not a drug class you want to continue indefinitely. This article walks through what long-term NSAID use actually does to the body and looks at joint injection using stem cell conditioned media as an alternative option, from the perspective of Dr. Moriwaki at AVAN TOKYO Ginza.

Key Points

・Long-term NSAID use raises the risk of gastric mucosal injury and declining renal function in a stepwise manner.

・Framing the problem only as “suppress the pain” makes it hard to leave the drug behind — you need a view that also addresses the inflammatory environment inside the joint.

・Joint injection of stem cell conditioned media targets anti-inflammatory action and repair-supportive tissue environment at the same time, with little systemic burden on stomach or kidneys.

・Zeroing the drug is not the point — bringing use down to occasional as-needed dosing is a realistic goal.

・Protecting the stomach and kidneys while keeping the joint functional over the long haul requires a design that combines injection, exercise therapy, and weight management.

What Long-Term NSAID Use Is Doing to the Stomach and Kidneys

NSAIDs (non-steroidal anti-inflammatory drugs) are widely prescribed painkillers — loxoprofen, diclofenac, celecoxib, and others. They are frequently prescribed at orthopedic clinics for chronic knee, back, or shoulder pain, and because many are available over the counter, it is not unusual for someone to have been taking them for years without realizing it.

How Gastric Mucosal Injury Occurs

NSAIDs block cyclooxygenase (COX) to suppress pain and inflammation. COX-1, however, is also involved in producing the prostaglandins that protect the gastric mucosa, so blocking it lowers mucosal blood flow and mucus secretion. The result is what is called an NSAID ulcer — a gastric or duodenal ulcer that can progress to gastrointestinal bleeding. The risk rises sharply with concurrent Helicobacter pylori infection, older age, or the use of anticoagulants, so anyone taking multiple medications for chronic conditions needs to be especially careful.

How Renal Function Declines

The glomerulus in the kidney maintains its filtration function by keeping the afferent arteriole dilated to preserve blood flow. Prostaglandins are involved in that dilation, and long-term NSAID use interferes with this regulation. In the presence of dehydration, heart failure, older age, or concurrent diuretic use, NSAID-associated renal injury becomes more likely, and it is well recognized to hasten the progression of chronic kidney disease (CKD). If checkups have shown creatinine drifting upward or eGFR trending downward, it is time to rethink the painkiller regimen. The Japanese Orthopaedic Association also recommends avoiding open-ended, drift-along long-term NSAID prescription for chronic joint pain.

培養幹細胞(関節)

Why It Is So Hard to Get Off a Drug That Works

The biggest reason it is so hard to escape long-term NSAID use is the sheer immediacy of the effect: take one, and within a few hours the pain lifts and life gets moving again. The joint degeneration and chronic inflammation themselves are not being cured — only the pain is being temporarily silenced — but for someone who has to get through the day, it is a very hard drug to put down.

“Suppressing Inflammation” Alone Does Not Change the Environment

In conditions such as knee osteoarthritis or chronic low back pain, inflammatory cytokines (IL-1β, TNF-α, and others) are continuously produced inside the joint, forming a vicious cycle that gradually damages cartilage and synovium. Painkillers suppress the “pain” at the downstream end of that cycle, but they do not touch the upstream intra-articular environment itself. That is exactly why the pain comes back the moment the drug is stopped — and why the pattern easily slides into a dependent one where daily life feels impossible without the medication.

How This Differs From Topical Patches and Steroid Injections

Topical NSAID patches have less systemic absorption, but for chronic joint pain the analgesic effect is often insufficient. Steroid joint injections powerfully suppress inflammation, but repeating them frequently has been flagged as burdensome on cartilage and tendons — again, not well suited to “a treatment you keep coming back to.” A supposedly protective option can turn into another dead-end.

Joint Injection of Stem Cell Conditioned Media as an Alternative

Stem cell conditioned media is a liquid fraction containing the cytokines, growth factors, and exosomes that mesenchymal stem cells secrete when cultured. Rather than injecting the cells themselves, this therapy uses the “signaling factors the cells released,” and its distinctive feature is that it aims for anti-inflammatory action and a repair-supportive tissue environment at the same time. For more, see our page on joint injection with stem cell conditioned media.

A Two-Layer Design: “Suppress Inflammation” + “Reset the Environment”

Basic research shows that the TGF-β, IGF-1, and HGF contained in conditioned media can suppress the action of inflammatory cytokines while nudging chondrocytes and synovial cells toward repair-oriented signaling. Oral painkillers “temporarily silence pain”; conditioned media aims to “calm the environment in which inflammation is being generated inside the joint.” The effect tends to build gradually over 2–4 weeks post-injection. Framed honestly, this is a treatment that builds the ground on which you can reduce the drug — not one that instantly replaces it.

Minimal Systemic Burden on the Stomach and Kidneys

Because conditioned media is administered locally inside the joint, the gastric- and renal-side burden associated with systemic NSAIDs is essentially not expected. People at higher risk from long-term NSAID use — the elderly, those with CKD history, prior gastric ulcer, or ongoing anticoagulant use — are precisely the group in whom this option is worth considering. It is not, however, suitable for joints with active infection, end-stage joint destruction, or unstable systemic conditions. Suitability is judged carefully by combining clinical examination, imaging, and blood work.

Designing a Path Out of Painkillers

An abrupt attempt to leave painkillers behind will almost always trigger a rebound of pain and lead you to bump the dose right back up. The realistic exit plan is to reset the goal — not “zero medication,” but “back to a level where occasional as-needed dosing gets you through.”

Run Injection, Exercise Therapy, and Weight Management in Parallel

Joint injection of conditioned media alone will not get you off painkillers. Combining several tracks — quadriceps-focused exercise therapy, weight management, protective supports like braces or a cane, and where appropriate, hyaluronic acid injection or short courses of steroid injection — is what makes it feasible to reduce painkiller frequency in a stepwise way. Paradoxically, not forcing the pace is the fastest route.

Create Drug-Free Days First, Then Reduce

For anyone in the middle of long-term NSAID use, the first goal is to bring baseline pain down to a level where you can carve out drug-free days. Once that is possible, shift into as-needed dosing a few days per week, and — in coordination with your internist — start stepping down gastric protectants (PPIs, H2 blockers) as well. This is a graded reduction guided by symptoms and blood work on renal function, not an abrupt stop. In the days immediately after each joint injection, avoid pain flare-ups and heavy loading, share your course with the physician, and decide the next step together.

FAQ

Q. I take painkillers every day. If I have joint injection with conditioned media, can I stop the medication?

Not everyone can zero it out. For many people, getting to “as needed, once every few days” already reduces the burden on the stomach and kidneys substantially. The goal is not zero but a safe frequency you can live with.

Q. I’ve already been told I have chronic kidney disease (CKD). Can I still receive conditioned media joint injection?

Conditioned media is administered locally into the joint, so a direct renal burden is essentially not expected. It is precisely people with CKD, for whom long-term NSAID use is difficult, who have the most to gain from considering this option. Active infection or unstable systemic status may still lead us to defer, so decisions are made in coordination with your nephrologist.

Q. When can I expect the effect, and how long does it last?

It depends on the joint and the stage of disease, but many patients begin to notice reduced pain in daily activities 2–4 weeks after injection, with reports of the effect lasting from several months to about six months. A common design is a shorter-interval induction phase (2–3 sessions initially) followed by a maintenance phase.

Q. How is this different from steroid joint injection?

Steroids suppress inflammation powerfully, but repeating them frequently has been flagged for potential effects on cartilage and tendons — so they are not ideal for repeated use over time. Conditioned media aims not only to suppress inflammation but also to reset the intra-articular environment, making it a better fit for a long-term “stay-the-course” strategy.

Q. Is this covered by insurance?

Because this is a self-pay treatment under Japan’s Act on the Safety of Regenerative Medicine, public health insurance does not apply. Judge the cost as a total figure, and be sure to confirm the estimate in advance, including the number of visits and maintenance-phase frequency. The final total is fixed at counseling.

──────────────

Supervising Physician: Shin Moriwaki, MD

Member, Japan Society of Aesthetic Surgery (JSAS) / American Academy of Aesthetic Medicine

ECFMG Certificate

──────────────

📍AVAN TOKYO Ginza Joint Regenerative Medicine

English / 中文 / Tiếng Việt supported

Inquiries via DM / LINE / Website / Phone.